The Board of Directors of Ajanta Pharma is scheduled to meet on November 3, 2025, to consider an equity dividend. The board will also review the unaudited financial results for the second quarter and half-year ended September 30, 2025. Additionally, the meeting will address the declaration of the 1st interim dividend for the financial year ending March 31, 2026.
Board Meeting Announcement
Ajanta Pharma has announced an upcoming board meeting where key financial decisions will be made. The meeting is scheduled for November 3, 2025.
Dividend and Financial Results
During the meeting, the Board of Directors will consider the declaration of an equity dividend. The board will also review and approve the unaudited financial results for Q2 and half-year, which concluded on September 30, 2025.
Interim Dividend Consideration
The Board will also consider the declaration of the 1st interim dividend for the financial year concluding on March 31, 2026. The record date for the dividend payment, if declared, is fixed for November 10, 2025.
Source: BSE
